Nipro operations note: why-i-stopped-buying-the-cheapest-dialysis-machines-and-what-i-look-86

I think most procurement teams in healthcare are asking the wrong question

When I took over purchasing for our dialysis center back in 2020, I was laser-focused on one thing: getting the lowest upfront price on dialysis machines. It seemed like the obvious priority, right? My boss in finance wanted to see cost savings. Operations wanted equipment that 'worked.' I figured any machine that met spec would do the job, so why pay more?

Three years and roughly 60 equipment orders later, I've come to believe that's a dangerous mindset—especially in a clinical setting. The cheapest option can end up costing way more than you'd expect, and not just in dollars. Let me explain.

The trigger event that changed my thinking

I didn't fully understand this until a specific incident in early 2023. We'd purchased a budget dialysis machine for a new satellite clinic. The price was about 20% below our usual range. Fast forward six months: the machine had recurring alarms that required two service calls. One was a software glitch; the other involved a part that wasn't in stock locally. Each call cost us a day of downtime, plus the technician's fee. Meanwhile, patients had to be rescheduled or sent to our main center—which meant upset patients and extra travel costs.

Looking back, that single purchase probably cost us around $4,000 more than the sticker price suggested, once you added service visits, lost patient time, and the headache of rescheduling. (Should mention: the vendor's support team was responsive, but their local service network just wasn't set up for quick fixes. That's a lesson in itself.)

Here's what I think really matters for dialysis equipment procurement

Let me be direct: I believe total cost of ownership, not sticker price, should drive your decision for any clinical device. And that's especially true for dialysis machines, where uptime and treatment consistency directly affect patient outcomes.

1. Total cost of ownership includes downtime risks

It took me a few years and a handful of experiences to understand this. The base price of a dialysis machine might be $X, but you're also paying for:

• Service contract costs (often not included in the initial quote)
• Downtime costs when a machine fails (lost revenue, rescheduling, overtime)
• Training costs for your clinical staff (some machines are way more intuitive than others)

I've seen a 'cheap' machine require an extra day of training for our nurses, which ate up the savings quickly. The machine that cost $3,000 more upfront? It integrated seamlessly with our existing workflow. No extra training needed. That saved us roughly $1,200 in staff time alone.

2. Clinical reliability is non-negotiable

If you've ever had a piece of equipment fail mid-treatment, you know that sinking feeling. Honestly, I'm not sure why some brands have consistently higher failure rates than others. My best guess is it comes down to component quality and testing rigor. But what I do know is this: for dialysis machines, reliability isn't a 'nice to have.' It's a requirement.

Our center runs roughly 1,200 treatments per month. A machine that's down for 5% of that time means 60 missed treatment slots. And that's not just a scheduling headache—it affects patient care directly. So when I evaluate a brand now, I ask for service records or uptime data. If they can't provide it, that's a red flag.

3. Supplier support and network matter more than you think

Here's something that surprised me: the vendor's ability to provide technical support and parts quickly is just as important as the machine's specification. I've dealt with brands that had great equipment but a sparse local service network. When something breaks—and it will, eventually—you need someone who can respond in hours, not days.

I'm not saying you should only buy from the biggest names. But I am saying you should verify the support infrastructure before signing. Ask about local service technicians, parts availability, and average response times. If a vendor hesitates on those questions, that's another red flag.

But what about budget pressure? I hear you.

I know that many procurement teams are under pressure to show immediate cost savings. Finance wants a lower PO amount this quarter. I get it—I report to finance too. But in my experience, the 'savings' from a cheap machine disappear fast when you factor in service costs and downtime. Plus, when a machine fails and disrupts patient care, you look bad to operations. I'd rather spend 10 minutes explaining my rationale for a slightly higher upfront cost than deal with the fallout of a poor reliability choice.

That said, I'm not saying every expensive machine is worth it. You still need to evaluate each option carefully. But I've stopped treating price as the primary filter. Instead, I look at total cost of ownership—and that has saved us way more money over the long run.

So here's my current approach

When I evaluate dialysis machines now, I ask three questions:

1. What's the total cost of ownership over 3 years? Not just the purchase price, but service contracts, expected maintenance frequency, and training costs.
2. What's the vendor's local support network like? Can they respond to a service call within 24 hours? Do they have parts stocked regionally?
3. Does the machine integrate with our existing system and workflow? Or will it create additional training and process friction?

I think healthcare procurement teams sometimes over-index on upfront cost, especially when budgets are tight. I've done it myself. But I've learned that the cheapest option is rarely the correct one for clinical equipment. An informed buyer asks better questions and makes faster decisions. And an informed buyer—one who understands total cost of ownership—is better for everyone: finance, operations, and most importantly, patients.